{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:12:25Z","timestamp":1791947545630,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20151587"],"award-info":[{"award-number":["BK20151587"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.biopha.2022.114024","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T01:31:13Z","timestamp":1668648673000},"page":"114024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3\/CPT1 pathway"],"prefix":"10.1016","volume":"157","author":[{"given":"Peng","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3119-4322","authenticated-orcid":false,"given":"Xiangjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.biopha.2022.114024_bib1","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biopha.2022.114024_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.amjcard.2004.01.039","article-title":"Statin therapy is associated with lower mortality among patients with severe heart failure","volume":"93","author":"Mozaffarian","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2022.114024_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.atherosclerosis.2010.11.008","article-title":"Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels","volume":"214","author":"Bot","year":"2011","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.biopha.2022.114024_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22295","article-title":"Protective effect of atorvastatin on oxidative stress in streptozotocin-induced diabetic rats independently their lipid-lowering effects","volume":"33","author":"Aktay","year":"2019","journal-title":"J. Biochem Mol. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2022.114024_bib5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/hq0202.104081","article-title":"Cellular antioxidant effects of atorvastatin in vitro and in vivo","volume":"22","author":"Wassmann","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2022.114024_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.biopha.2022.114024_bib7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.bbalip.2016.03.020","article-title":"Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes","volume":"1861","author":"Fukushima","year":"2016","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2022.114024_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbalip.2009.09.023","article-title":"Lipotoxicity in the heart","volume":"1801","author":"Wende","year":"2010","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.biopha.2022.114024_bib9","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.119.043319","article-title":"Increasing fatty acid oxidation prevents high-fat diet-induced cardiomyopathy through regulating parkin-mediated mitophagy","volume":"142","author":"Shao","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.biopha.2022.114024_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41569-018-0074-0","article-title":"Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles","volume":"16","author":"Bonora","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2022.114024_bib11","doi-asserted-by":"crossref","first-page":"9602","DOI":"10.1002\/jcb.27068","article-title":"A high-fat diet impairs mitochondrial biogenesis, mitochondrial dynamics, and the respiratory chain complex in rat myocardial tissues","volume":"119","author":"Chen","year":"2018","journal-title":"J. Cell Biochem"},{"issue":"9","key":"10.1016\/j.biopha.2022.114024_bib12","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1161\/CIRCRESAHA.118.314607","article-title":"Mitophagy is essential for maintaining cardiac function during high fat diet-induced diabetic cardiomyopathy","volume":"124","author":"Tong","year":"2019","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.114024_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/oby.2007.511","article-title":"Chronological approach of diet-induced alterations in muscle mitochondrial functions in rats","volume":"15","author":"Chans\u00e9aume","year":"2007","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.biopha.2022.114024_bib14","doi-asserted-by":"crossref","first-page":"E1169","DOI":"10.1152\/ajpendo.00263.2007","article-title":"Diet-induced modulation of mitochondrial activity in rat muscle","volume":"293","author":"Laurent","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.biopha.2022.114024_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2022.114024_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00395-007-0658-z","article-title":"Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis","volume":"102","author":"Fischer","year":"2007","journal-title":"Basic Res. Cardiol."},{"issue":"14","key":"10.1016\/j.biopha.2022.114024_bib17","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.111.075978","article-title":"Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity","volume":"126","author":"He","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.114024_bib18","article-title":"Inhibiting cardiac mitochondrial fatty acid oxidation attenuates myocardial injury in a rat model of cardiac arrest","volume":"2021","author":"Wang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.biopha.2022.114024_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.biopha.2022.114024_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 activation-induced fatty acid oxidation in CD8(+) T effector cells is critical for obesity-promoted breast tumor growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.biopha.2022.114024_bib21","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/1440-1681.13507","article-title":"Atorvastatin reverses high cholesterol-induced cardiac remodelling and regulates mitochondrial quality-control in a cholesterol-independent manner: an experimental study","volume":"48","author":"Zheng","year":"2021","journal-title":"Clin. Exp. Pharm. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.114024_bib22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MOL.0b013e3283613a94","article-title":"Cholesterol and atherosclerosis: modulation by oestrogen","volume":"24","author":"Barton","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.biopha.2022.114024_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118573","article-title":"The effects of alone and combination tamoxifen, raloxifene and estrogen on lipid profile and atherogenic index of ovariectomized type 2 diabetic rats","volume":"263","author":"Ebrahimi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.114024_bib24","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8115","article-title":"Comparative RNA-sequencing profiled the differential gene expression of liver in response to acetyl-CoA carboxylase inhibitor GS-0976 in a mouse model of NASH","volume":"7","author":"Lu","year":"2019","journal-title":"PeerJ"},{"issue":"39","key":"10.1016\/j.biopha.2022.114024_bib25","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.2174\/138161281939131127115940","article-title":"The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation","volume":"19","author":"Boengler","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.biopha.2022.114024_bib26","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s12035-017-0503-9","article-title":"Mitochondrial quality control and disease: insights into ischemia-reperfusion injury","volume":"55","author":"Anzell","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.biopha.2022.114024_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2022.114024_bib28","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/bph.12475","article-title":"Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy","volume":"171","author":"Fillmore","year":"2014","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2022.114024_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12933-015-0234-z","article-title":"Cardiospecific CD36 suppression by lentivirus-mediated RNA interference prevents cardiac hypertrophy and systolic dysfunction in high-fat-diet induced obese mice","volume":"14","author":"Zhang","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"issue":"10","key":"10.1016\/j.biopha.2022.114024_bib30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s11626-013-9668-3","article-title":"Fatty acid composition in fetal, neonatal, and cultured cardiomyocytes in rats","volume":"49","author":"Karimata","year":"2013","journal-title":"Vitr. Cell. Dev. Biol. Anim."},{"issue":"3","key":"10.1016\/j.biopha.2022.114024_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jchf.2014.09.009","article-title":"Improvement in cardiac energetics by perhexiline in heart failure due to dilated cardiomyopathy","volume":"3","author":"Beadle","year":"2015","journal-title":"JACC Heart Fail."},{"issue":"16","key":"10.1016\/j.biopha.2022.114024_bib32","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/CIRCULATIONAHA.109.934059","article-title":"Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy","volume":"122","author":"Abozguia","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2022.114024_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.634900","article-title":"Combined administration of metformin and atorvastatin attenuates diabetic cardiomyopathy by inhibiting inflammation, apoptosis, and oxidative stress in type 2 diabetic mice","volume":"9","author":"Jia","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"14","key":"10.1016\/j.biopha.2022.114024_bib34","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1089\/ars.2013.5416","article-title":"Mitophagy is required for acute cardioprotection by simvastatin","volume":"21","author":"Andres","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"16","key":"10.1016\/j.biopha.2022.114024_bib35","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.0000034047.70205.97","article-title":"Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation","volume":"106","author":"Indolfi","year":"2002","journal-title":"Circulation"},{"issue":"7285","key":"10.1016\/j.biopha.2022.114024_bib36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2022.114024_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00395-015-0509-2","article-title":"Cardioprotective function of mitochondrial-targeted and transcriptionally inactive STAT3 against ischemia and reperfusion injury","volume":"110","author":"Szczepanek","year":"2015","journal-title":"Basic Res. Cardiol."},{"issue":"8","key":"10.1016\/j.biopha.2022.114024_bib38","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","article-title":"Celastrol attenuates angiotensin II-induced cardiac remodeling by targeting STAT3","volume":"126","author":"Ye","year":"2020","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.biopha.2022.114024_bib39","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","article-title":"DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics","volume":"145","author":"Zhuang","year":"2022","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.biopha.2022.114024_bib40","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/oby.21665","article-title":"Cardiac-specific down-regulation of carnitine palmitoyltransferase-1b (CPT-1b) prevents cardiac remodeling in obese mice","volume":"24","author":"Zhang","year":"2016","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.biopha.2022.114024_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1113\/JP271301","article-title":"Mitochondrial dynamics, mitophagy and cardiovascular disease","volume":"594","author":"V\u00e1squez-Trincado","year":"2016","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2022.114024_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12933-017-0501-2","article-title":"Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice","volume":"16","author":"Ding","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"issue":"13","key":"10.1016\/j.biopha.2022.114024_bib43","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.7150\/thno.33684","article-title":"Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy","volume":"9","author":"Hu","year":"2019","journal-title":"Theranostics"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.114024_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11010-018-3459-9","article-title":"TFAM overexpression reduces pathological cardiac remodeling","volume":"454","author":"Kunkel","year":"2019","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2022.114024_bib45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","article-title":"Role of mitochondrial dysfunction in insulin resistance","volume":"102","author":"Kim","year":"2008","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.biopha.2022.114024_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.biopha.2022.114024_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6571484","article-title":"Neuroprotective effect of chlorogenic acid on mitochondrial dysfunction-mediated apoptotic death of DA neurons in a Parkinsonian Mouse Model","volume":"2020","author":"Singh","year":"2020","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222014135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222014135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:07:47Z","timestamp":1778242067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222014135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":47,"alternative-id":["S0753332222014135"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114024","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3\/CPT1 pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.114024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114024"}}